Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiujuan Qu

Showing results (31-40 of 254) with videos related to

Pageof 26
Sort By:
Frontiers in Immunology|October 2, 2024
Efficacy and safety of first-line treatments for advanced hepatocellular carcinoma patients: a systematic review and network meta-analysisJingyi Li, Bowen Yang, Zan Teng, et al.
Blood|November 8, 2003
Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-bXiujuan Qu, Kiyonao Sada, Shinkou Kyo, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 8, 2011
[Expressions of c-Cbl, Cbl-b and EGFR and its role of prognosis in NSCLC]Xin Jiao, Bo Jin, Xiujuan Qu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2016
Cbl-b regulates the sensitivity of cetuximab through ubiquitin-proteasome system in human gastric cancer cellsPing Yu, Yibo Fan, Xiujuan Qu, et al.
Cancer Management and Research|June 26, 2020
Assessment of Nine Driver Gene Mutations in Surgically Resected Samples from Patients with Non-Small-Cell Lung CancerShuo Wang, Xiujuan Qu, Lili Cao, et al.
Oncology Reports|May 21, 2014
Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cellsLing Xu, Xiujuan Qu, Heming Li, et al.
Blood|August 30, 2002
Regulation of FcepsilonRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cellsKiyonao Sada, S M Shahjahan Miah, Koichiro Maeno, et al.
International Journal of Molecular Sciences|April 10, 2014
Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cellsNa Song, Shizhou Liu, Jingdong Zhang, et al.
BMC Cancer|December 12, 2023
PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysisJia Zhao, Simeng Zhang, Xiaoyu Guo, et al.
Colloids and Surfaces. B, Biointerfaces|September 30, 2023
A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosisPuxiu Wang, Qiuhua Luo, Ling Zhang, et al.
Pageof 26

Showing results (31-40 of 254) with videos related to

Sort By:
Pageof 26
Frontiers in Immunology|October 2, 2024
Efficacy and safety of first-line treatments for advanced hepatocellular carcinoma patients: a systematic review and network meta-analysisJingyi Li, Bowen Yang, Zan Teng, et al.
Blood|November 8, 2003
Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-bXiujuan Qu, Kiyonao Sada, Shinkou Kyo, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 8, 2011
[Expressions of c-Cbl, Cbl-b and EGFR and its role of prognosis in NSCLC]Xin Jiao, Bo Jin, Xiujuan Qu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2016
Cbl-b regulates the sensitivity of cetuximab through ubiquitin-proteasome system in human gastric cancer cellsPing Yu, Yibo Fan, Xiujuan Qu, et al.
Cancer Management and Research|June 26, 2020
Assessment of Nine Driver Gene Mutations in Surgically Resected Samples from Patients with Non-Small-Cell Lung CancerShuo Wang, Xiujuan Qu, Lili Cao, et al.
Oncology Reports|May 21, 2014
Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cellsLing Xu, Xiujuan Qu, Heming Li, et al.
Blood|August 30, 2002
Regulation of FcepsilonRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cellsKiyonao Sada, S M Shahjahan Miah, Koichiro Maeno, et al.
International Journal of Molecular Sciences|April 10, 2014
Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cellsNa Song, Shizhou Liu, Jingdong Zhang, et al.
BMC Cancer|December 12, 2023
PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysisJia Zhao, Simeng Zhang, Xiaoyu Guo, et al.
Colloids and Surfaces. B, Biointerfaces|September 30, 2023
A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosisPuxiu Wang, Qiuhua Luo, Ling Zhang, et al.
Pageof 26